# Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

> **NCT01455610** · — · UNKNOWN · sponsor: **Meng Su Zeng** · enrollment: 140 (estimated)

## Conditions studied

- Adenocarcinoma of Head of Pancreas

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01455610
- **Lead sponsor:** Meng Su Zeng
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2011-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455610, "Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01455610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*